Alatrofloxacin
Alternative Names: Alatrofloxacin injection; Alatrofloxacin IV; CP-116,517; Trovan IV; Turvel IVLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Pfizer
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Bacterial-infections in Japan (IV, Infusion)
- 19 Jun 2002 A clinical study has been added to the adverse events and Bacterial Infections therapeutic trials sections
- 23 Oct 2000 Pfizer and Roerig have voluntarily withdrawn its marketing authorisations for both alatrofloxacin and trovafloxacin in the European Union